Immune Checkpoint Blockade plus Axitinib for Renal-Cell Carcinoma

N Engl J Med. 2019 Jun 27;380(26):2581. doi: 10.1056/NEJMc1905518.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Axitinib
  • Carcinoma, Renal Cell*
  • Humans
  • Kidney Neoplasms*
  • Sunitinib

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Axitinib
  • avelumab
  • Sunitinib